Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials.
Mensing S, Eckert D, Sharma S, Polepally AR, Khatri A, Podsadecki TJ, Awni WM, Menon RM, Dutta S. Mensing S, et al. Among authors: polepally ar. Br J Clin Pharmacol. 2017 Mar;83(3):527-539. doi: 10.1111/bcp.13138. Epub 2016 Nov 3. Br J Clin Pharmacol. 2017. PMID: 27662429 Free PMC article.
Clinical Pharmacokinetics of Paritaprevir.
Menon RM, Polepally AR, Khatri A, Awni WM, Dutta S. Menon RM, et al. Among authors: polepally ar. Clin Pharmacokinet. 2017 Oct;56(10):1125-1137. doi: 10.1007/s40262-017-0520-x. Clin Pharmacokinet. 2017. PMID: 28236252 Review.
Application of Exposure-Response Analyses to Establish the Pharmacodynamic Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen for the Treatment of HCV Infection.
Polepally AR, Wang H, Marroum PJ, Minocha M, Hosmane B, Khatri A, Mensing S, Podsadecki TJ, Cohen DE, Awni WM, Menon RM. Polepally AR, et al. AAPS J. 2017 Sep;19(5):1523-1535. doi: 10.1208/s12248-017-0115-3. Epub 2017 Jul 6. AAPS J. 2017. PMID: 28685397 Clinical Trial.
30 results